11/12
08:33 am
canf
Can-Fite BioPharma Ltd. (NYSE: CANF) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Can-Fite BioPharma Ltd. (NYSE: CANF) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
11/11
07:00 am
canf
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
Medium
Report
Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial
11/4
07:13 am
canf
Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia [Yahoo! Finance]
Medium
Report
Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia [Yahoo! Finance]
11/4
07:08 am
canf
Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia
High
Report
Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia
10/30
02:07 am
canf
Can-Fite BioPharma Ltd. (NYSE: CANF) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Can-Fite BioPharma Ltd. (NYSE: CANF) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
10/22
02:02 am
canf
Can-Fite BioPharma Ltd. (NYSE: CANF) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Can-Fite BioPharma Ltd. (NYSE: CANF) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
10/18
09:06 am
canf
Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson
Low
Report
Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson
10/14
11:07 pm
canf
Can-Fite BioPharma Ltd. (NYSE: CANF) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
High
Report
Can-Fite BioPharma Ltd. (NYSE: CANF) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/12
09:23 am
canf
Form 6-K Can-Fite BioPharma Ltd. For: Nov 11
Low
Report
Form 6-K Can-Fite BioPharma Ltd. For: Nov 11
11/4
07:10 am
canf
Form 6-K Can-Fite BioPharma Ltd. For: Nov 04
Medium
Report
Form 6-K Can-Fite BioPharma Ltd. For: Nov 04
10/18
09:24 am
canf
Form 6-K Can-Fite BioPharma Ltd. For: Oct 18
Low
Report
Form 6-K Can-Fite BioPharma Ltd. For: Oct 18
10/9
07:03 am
canf
Form 6-K Can-Fite BioPharma Ltd. For: Oct 09
Medium
Report
Form 6-K Can-Fite BioPharma Ltd. For: Oct 09
9/24
07:05 am
canf
Form 6-K Can-Fite BioPharma Ltd. For: Sep 24
High
Report
Form 6-K Can-Fite BioPharma Ltd. For: Sep 24
9/16
07:08 am
canf
Form 6-K Can-Fite BioPharma Ltd. For: Sep 16
Low
Report
Form 6-K Can-Fite BioPharma Ltd. For: Sep 16
9/9
06:02 am
canf
Form EFFECT Can-Fite BioPharma Ltd.
Low
Report
Form EFFECT Can-Fite BioPharma Ltd.
9/6
04:31 pm
canf
Form 424B3 Can-Fite BioPharma Ltd.
Medium
Report
Form 424B3 Can-Fite BioPharma Ltd.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register